Trials / Completed
CompletedNCT02310724
TODAY2 Phase 2 Follow-up
Long-term Post-Intervention Follow-up of the TODAY Cohort (Treatment Options for Type 2 Diabetes in Youth and Adolescents)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 517 (actual)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of T2P2 is to track the progression of T2D and related comorbidities and complications in the TODAY cohort as they transition to young adulthood. We hypothesize that: * Youth-onset type 2 diabetes (T2D) will progress rapidly and result in high rates of diabetes-related medical complications and comorbidities. * The rapid rate of progression is related to increased insulin resistance characteristic of puberty, worse β-cell function, degree of glycemic control, control of non-glycemic factors, and obesity itself.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | TODAY cohort | This protocol is observation only and involves no intervention, care, treatment, or management. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2020-01-17
- Completion
- 2020-01-17
- First posted
- 2014-12-08
- Last updated
- 2021-08-05
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02310724. Inclusion in this directory is not an endorsement.